Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clarisse Marcombes

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Investigative Dermatology|March 30, 2023
First-Line Persistence of Biologics in Psoriasis from a Cohort Based on French Medico-Administrative DataClarisse Marcombes, Laetitia Penso, Emilie Sbidian
The British Journal of Dermatology|July 21, 2023
Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS)Clarisse Marcombes, Laetitia Penso, Alain Weill, et al.
Contact Dermatitis|May 1, 2025
Positive Osimertinib Patch Test in a Bullous Lichenoid Drug ReactionClarisse Marcombes, Kamar Bel Hareth, Héloïse Mazoyer, et al.
Age and Ageing|August 5, 2021
Syphilis has no age limitClarisse Marcombes, Barbara Papouin, Nicolas Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 31, 2025
French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025Marie Masson Regnault, Emilie Brenaut, Marie-Emeline Marniquet, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Investigative Dermatology|March 30, 2023
First-Line Persistence of Biologics in Psoriasis from a Cohort Based on French Medico-Administrative DataClarisse Marcombes, Laetitia Penso, Emilie Sbidian
The British Journal of Dermatology|July 21, 2023
Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS)Clarisse Marcombes, Laetitia Penso, Alain Weill, et al.
Contact Dermatitis|May 1, 2025
Positive Osimertinib Patch Test in a Bullous Lichenoid Drug ReactionClarisse Marcombes, Kamar Bel Hareth, Héloïse Mazoyer, et al.
Age and Ageing|August 5, 2021
Syphilis has no age limitClarisse Marcombes, Barbara Papouin, Nicolas Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 31, 2025
French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025Marie Masson Regnault, Emilie Brenaut, Marie-Emeline Marniquet, et al.
Pageof 1